Vanguard Personalized Indexing Management, LLC Eagle Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 15,530 shares of EGRX stock, worth $11,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,530
Previous 13,629
13.95%
Holding current value
$11,647
Previous $76,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
70Shares Held
9.32MCall Options Held
1.01MPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.96MShares$1.47 Million0.73% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.21MShares$908,6311.82% of portfolio
-
Citigroup Inc1MShares$750,2910.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT697KShares$522,5970.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA580KShares$434,6300.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $9.76M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...